BioNTech AG announced that it has entered into an agreement with existing investor Sanofi (ENXTPA:SAN) for gross proceeds of 80 million in funding on January 4, 2019. The company will issue common shares in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.82 USD | +3.05% |
|
+7.84% | -17.74% |
07-15 | BIONTECH : In transition | ![]() |
07-12 | European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.74% | 20.95B | |
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B | |
+151.63% | 12.57B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech AG announced that it expects to receive €80 million in funding from Sanofi